Key Points
-
The competitive endogenous RNA (ceRNA) hypothesis posits that transcripts with shared microRNA binding sites compete for post-transcriptional control.
-
Experimental evidence is accumulating that describes ceRNA function for long non-coding RNAs, pseudogene transcripts, circular RNAs, viral RNAs as well as protein-coding transcripts.
-
Studies that quantitatively model transcriptome-wide ceRNA networks are challenging claims of the scale and potential effects of the ceRNA mechanism for individual transcripts.
-
Methodological limitations to both experimental and in silico evidence are explored to provide an objective assessment of the implications of the ceRNA hypothesis.
Abstract
The competitive endogenous RNA (ceRNA) hypothesis proposes that transcripts with shared microRNA (miRNA) binding sites compete for post-transcriptional control. This hypothesis has gained substantial attention as a unifying function for long non-coding RNAs, pseudogene transcripts and circular RNAs, as well as an alternative function for messenger RNAs. Empirical evidence supporting the hypothesis is accumulating but not without attracting scepticism. Recent studies that model transcriptome-wide binding-site abundance suggest that physiological changes in expression of most individual transcripts will not compromise miRNA activity. In this Review, we critically evaluate the evidence for and against the ceRNA hypothesis to assess the impact of endogenous miRNA-sponge interactions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Quek, X. C. et al. lncRNAdb v2.0: expanding the reference database for functional long noncoding RNAs. Nucleic Acids Res. 43, D168–D173 (2015).
Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P. P. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell 146, 353–358 (2011). This commentary introduced the hypothesis that RNA–RNA competition and crosstalk could universally affect gene expression, coining the term 'ceRNA hypothesis'.
Broderick, J. A. & Zamore, P. D. Competitive endogenous RNAs cannot alter microRNA function in vivo. Mol. Cell 54, 711–713 (2014).
Denzler, R., Agarwal, V., Stefano, J., Bartel, D. P. & Stoffel, M. Assessing the ceRNA hypothesis with quantitative measurements of miRNA and target abundance. Mol. Cell 54, 766–776 (2014). This study used quantitative measurements of target abundance and controlled overexpression to conclude that physiological expression of individual competing transcripts was insufficient to silence miR-122, a miRNA that is highly expressed in liver.
Bosson, A. D., Zamudio, J. R. & Sharp, P. A. Endogenous miRNA and target concentrations determine susceptibility to potential ceRNA competition. Mol. Cell 56, 347–359 (2014). This study measured the active miRNA target pool using AGO iCLIP to show that the majority of active miRNAs are probably not susceptible to ceRNA competition. Although exceptionally low target abundance can create a scenario of physiological RNA competition, such as the example of the miR-25 miRNA family.
Jens, M. & Rajewsky, N. Competition between target sites of regulators shapes post-transcriptional gene regulation. Nat. Rev. Genet. 16, 113–126 (2015). This study used quantitative modelling of competitive RNA interactions under physiological conditions to show that competition for miRNA binding, without exceptional circumstances, requires unphysiological changes in target site abundance.
Ala, U. et al. Integrated transcriptional and competitive endogenous RNA networks are cross-regulated in permissive molecular environments. Proc. Natl Acad. Sci. USA 110, 7154–7159 (2013).
Bosia, C., Pagnani, A. & Zecchina, R. Modelling competing endogenous RNA networks. PLoS ONE 8, e66609 (2013).
Figliuzzi, M., Marinari, E. & De Martino, A. MicroRNAs as a selective channel of communication between competing RNAs: a steady-state theory. Biophys. J. 104, 1203–1213 (2013).
Yuan, Y. et al. Model-guided quantitative analysis of microRNA-mediated regulation on competing endogenous RNAs using a synthetic gene circuit. Proc. Natl Acad. Sci. USA 112, 3158–3163 (2015).
Kartha, R. V. & Subramanian, S. Competing endogenous RNAs (ceRNAs): new entrants to the intricacies of gene regulation. Front. Genet. 5, 8 (2014).
Li, J. H., Liu, S., Zhou, H., Qu, L. H. & Yang, J. H. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 42, D92–D97 (2014).
Sarver, A. L. & Subramanian, S. Competing endogenous RNA database. Bioinformation 8, 731–733 (2012).
Das, S., Ghosal, S., Sen, R. & Chakrabarti, J. lnCeDB: database of human long noncoding RNA acting as competing endogenous RNA. PLoS ONE 9, e98965 (2014).
Chiu, H. S. et al. Cupid: simultaneous reconstruction of microRNA–target and ceRNA networks. Genome Res. 25, 257–267 (2015).
Yip, D. K., Pang, I. K. & Yip, K. Y. Systematic exploration of autonomous modules in noisy microRNA–target networks for testing the generality of the ceRNA hypothesis. BMC Genomics 15, 1178 (2014).
Wang, P. et al. miRSponge: a manually curated database for experimentally supported miRNA sponges and ceRNAs. Database (Oxford) 2015, bav098 (2015).
Cheng, D. L., Xiang, Y. Y., Ji, L. J. & Lu, X. J. Competing endogenous RNA interplay in cancer: mechanism, methodology, and perspectives. Tumour Biol. 36, 479–488 (2015).
Figliuzzi, M., De Martino, A. & Marinari, E. RNA-based regulation: dynamics and response to perturbations of competing RNAs. Biophys. J. 107, 1011–1022 (2014).
Wang, P. et al. Identification of lncRNA-associated competing triplets reveals global patterns and prognostic markers for cancer. Nucleic Acids Res. 43, 3478–3489 (2015).
Paci, P., Colombo, T. & Farina, L. Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer. BMC Syst. Biol. 8, 83 (2014).
Mullokandov, G. et al. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat. Methods 9, 840–846 (2012). Using a high-throughput assay for miRNA function (Sensor-seq), this study found that miRNA activity was a product of its high abundance; however, some moderately expressed miRNAs with lower activity could be explained by having exceptionally larger target abundance.
Meister, G., Landthaler, M., Dorsett, Y. & Tuschl, T. Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing. RNA 10, 544–550 (2004).
Krutzfeldt, J. et al. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685–689 (2005).
Orom, U. A., Kauppinen, S. & Lund, A. H. LNA-modified oligonucleotides mediate specific inhibition of microRNA function. Gene 372, 137–141 (2006).
Brown, B. D. et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat. Biotechnol. 25, 1457–1467 (2007).
Care, A. et al. MicroRNA-133 controls cardiac hypertrophy. Nat. Med. 13, 613–618 (2007).
Ebert, M. S., Neilson, J. R. & Sharp, P. A. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods 4, 721–726 (2007). This was the first work to describe the use of an artificial introduced antisense miRNA sponge as a tool for miRNA inhibition.
Farooqi, A. A., Rehman, Z. U. & Muntane, J. Antisense therapeutics in oncology: current status. Onco. Targets Ther. 7, 2035–2042 (2014).
Ebert, M. S. & Sharp, P. A. MicroRNA sponges: progress and possibilities. RNA 16, 2043–2050 (2010).
Elmen, J. et al. LNA-mediated microRNA silencing in non-human primates. Nature 452, 896–899 (2008).
Haraguchi, T., Ozaki, Y. & Iba, H. Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res. 37, e43 (2009).
Cheng, C. J. & Saltzman, W. M. Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing. Mol. Pharm. 9, 1481–1488 (2012).
Ebert, M. S. & Sharp, P. A. Emerging roles for natural microRNA sponges. Curr. Biol. 20, R858–R861 (2010).
Davis, S., Lollo, B., Freier, S. & Esau, C. Improved targeting of miRNA with antisense oligonucleotides. Nucleic Acids Res. 34, 2294–2304 (2006).
Thomson, D. W., Bracken, C. P., Szubert, J. M. & Goodall, G. J. On measuring miRNAs after transient transfection of mimics or antisense inhibitors. PLoS ONE 8, e55214 (2013).
Crooke, R. M. & Graham, M. J. Modulation of lipoprotein metabolism by antisense technology: preclinical drug discovery methodology. Methods Mol. Biol. 1027, 309–324 (2013).
Esau, C. C. Inhibition of microRNA with antisense oligonucleotides. Methods 44, 55–60 (2008).
Hansen, T. B. et al. Natural RNA circles function as efficient microRNA sponges. Nature 495, 384–388 (2013). This study used a custom sequencing pipeline to investigate widespread circRNA expression and shows that a circRNA derived from Sry could act as a sponge for miR-138.
Memczak, S. et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495, 333–338 (2013).
Wang, L. et al. Pseudogene OCT4-pg4 functions as a natural micro RNA sponge to regulate OCT4 expression by competing for miR-145 in hepatocellular carcinoma. Carcinogenesis 34, 1773–1781 (2013).
Marques, A. C. et al. Evidence for conserved post-transcriptional roles of unitary pseudogenes and for frequent bifunctionality of mRNAs. Genome Biol. 13, R102 (2012).
Poliseno, L. et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033–1038 (2010).
Johnsson, P. et al. A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nat. Struct. Mol. Biol. 20, 440–446 (2013).
Yu, G. et al. Pseudogene PTENP1 functions as a competing endogenous RNA to suppress clear-cell renal cell carcinoma progression. Mol. Cancer Ther. 13, 3086–3097 (2014).
Zheng, L., Li, X., Gu, Y., Lv, X. & Xi, T. The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1. Breast Cancer Res. Treat. 150, 105–118 (2015).
Franco-Zorrilla, J. M. et al. Target mimicry provides a new mechanism for regulation of microRNA activity. Nat. Genet. 39, 1033–1037 (2007).
Wang, J. et al. CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res. 38, 5366–5383 (2010).
Liu, Q. et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 41, 4976–4987 (2013).
Wang, Y. et al. Endogenous miRNA sponge lincRNA-RoR regulates Oct4, Nanog, and Sox2 in human embryonic stem cell self-renewal. Dev. Cell 25, 69–80 (2013).
Cesana, M. et al. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 147, 358–369 (2011).
Fan, M. et al. A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells. Exp. Ther. Med. 5, 1143–1146 (2013).
Fang, L. et al. Versican 3′-untranslated region (3′-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity. FASEB J. 27, 907–919 (2013).
Zheng, T. et al. CXCR4 3′UTR functions as a ceRNA in promoting metastasis, proliferation and survival of MCF-7 cells by regulating miR-146a activity. Eur. J. Cell Biol. 458–469 (2015).
Cazalla, D., Yario, T. & Steitz, J. A. Down-regulation of a host microRNA by a Herpesvirus saimiri noncoding RNA. Science 328, 1563–1566 (2010). This was the first report of viral non-coding RNAs acting as miRNA sponges in infected host cells, namely the HSUR RNAs of HVS. This was also the first report of snRNAs acting as ceRNAs.
Lee, S. et al. Selective degradation of host MicroRNAs by an intergenic HCMV noncoding RNA accelerates virus production. Cell Host Microbe 13, 678–690 (2013).
Luna, J. M. et al. Hepatitis C virus RNA functionally sequesters miR-122. Cell 160, 1099–1110 (2015). Using AGO HITS–CLIP and single cell measurements, this study showed that genomic RNA from HCV sequesters host miR-122 upon infection, offering a mechanism were ceRNA activity is amplified via a positive feedback loop where the virus is also stabilized by miR-122.
Cabili, M. N. et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 25, 1915–1927 (2011).
Derrien, T. et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 22, 1775–1789 (2012).
Dinger, M. E., Gascoigne, D. K. & Mattick, J. S. The evolution of RNAs with multiple functions. Biochimie 93, 2013–2018 (2011).
Gao, S. et al. IGF1 3'UTR functions as a ceRNA in promoting angiogenesis by sponging miR-29 family in osteosarcoma. J. Mol. Histol. 47, 135–143 (2016).
Jeyapalan, Z. et al. Expression of CD44 3′-untranslated region regulates endogenous microRNA functions in tumorigenesis and angiogenesis. Nucleic Acids Res. 39, 3026–3041 (2011).
Rutnam, Z. J. & Yang, B. B. The non-coding 3′ UTR of CD44 induces metastasis by regulating extracellular matrix functions. J. Cell Sci. 125, 2075–2085 (2012).
Lee, D. Y. et al. Expression of versican 3′-untranslated region modulates endogenous microRNA functions. PLoS ONE 5, e13599 (2010).
Yang, J. et al. FOXO1 3'UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity. FEBS Lett. 588, 3218–3224 (2014).
Li, D. et al. OCT4B modulates OCT4A expression as ceRNA in tumor cells. Oncol. Rep. 33, 2622–2630 (2015).
Liu, K. et al. AEG-1 3′-untranslated region functions as a ceRNA in inducing epithelial-mesenchymal transition of human non-small cell lung cancer by regulating miR-30a activity. Eur. J. Cell Biol. 94, 22–31 (2015).
Tay, Y. et al. Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell 147, 344–357 (2011).
Karreth, F. A. et al. In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma. Cell 147, 382–395 (2011).
Sumazin, P. et al. An extensive microRNA-mediated network of RNA–RNA interactions regulates established oncogenic pathways in glioblastoma. Cell 147, 370–381 (2011).
Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15–20 (2005).
John, B. et al. Human microRNA targets. PLoS Biol. 2, e363 (2004).
Jeggari, A. & Marks, D. S. & Larsson, E. miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics 28, 2062–2063 (2012).
Paraskevopoulou, M. D. et al. DIANA-LncBase: experimentally verified and computationally predicted microRNA targets on long non-coding RNAs. Nucleic Acids Res. 41, D239–D245 (2013).
Karreth, F. A. et al. The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo. Cell 161, 319–332 (2015). This work showed that a BRAF pseudogene acts as a ceRNA.
Kuhn, D. E. et al. Experimental validation of miRNA targets. Methods 44, 47–54 (2008).
Thomson, D. W., Bracken, C. P. & Goodall, G. J. Experimental strategies for microRNA target identification. Nucleic Acids Res. 39, 6845–6853 (2011).
Arvey, A., Larsson, E., Sander, C., Leslie, C. S. & Marks, D. S. Target mRNA abundance dilutes microRNA and siRNA activity. Mol. Syst. Biol. 6, 363 (2010).
Anderson, E. M. et al. Experimental validation of the importance of seed complement frequency to siRNA specificity. RNA 14, 853–861 (2008).
Garcia, D. M. et al. Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs. Nat. Struct. Mol. Biol. 18, 1139–1146 (2011).
Bracken, C. P. et al. Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion. EMBO J. 33, 2040–2056 (2014).
Chi, S. W., Zang, J. B., Mele, A. & Darnell, R. B. Argonaute HITS-CLIP decodes microRNA–mRNA interaction maps. Nature 460, 479–486 (2009).
Pei, B. et al. The GENCODE pseudogene resource. Genome Biol. 13, R51 (2012).
Milligan, M. J. & Lipovich, L. Pseudogene-derived lncRNAs: emerging regulators of gene expression. Front. Genet. 5, 476 (2014).
Kim, M. S. et al. A draft map of the human proteome. Nature 509, 575–581 (2014).
Wilusz, J. E. & Sharp, P. A. Molecular biology. A circuitous route noncoding RNA. Science 340, 440–441 (2013).
Conn, S. J. et al. The RNA binding protein quaking regulates formation of circRNAs. Cell 160, 1125–1134 (2015).
Capel, B. et al. Circular transcripts of the testis-determining gene Sry in adult mouse testis. Cell 73, 1019–1030 (1993).
Rybak-Wolf, A. et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol. Cell (2015).
Lasda, E. & Parker, R. Circular RNAs: diversity of form and function. RNA 20, 1829–1842 (2014).
Guo, J. U., Agarwal, V., Guo, H. & Bartel, D. P. Expanded identification and characterization of mammalian circular RNAs. Genome Biol. 15, 409 (2014). This work analysed circRNA transcription; among other analyses they noted that miRNA binding sites within circRNAs were not widespread, with the exception of the reported example of the circRNA from Sry.
Jeck, W. R. & Sharpless, N. E. Detecting and characterizing circular RNAs. Nat. Biotechnol. 32, 453–461 (2014).
Jeck, W. R. et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 19, 141–157 (2013).
Li, F. et al. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway. Oncotarget 6, 6001–6013 (2015).
Suzuki, H. & Tsukahara, T. A view of pre-mRNA splicing from RNase R resistant RNAs. Int. J. Mol. Sci. 15, 9331–9342 (2014).
Hansen, T. B. et al. miRNA-dependent gene silencing involving Ago2-mediated cleavage of a circular antisense RNA. EMBO J. 30, 4414–4422 (2011).
McCaskill, J., Praihirunkit, P., Sharp, P. M. & Buck, A. H. RNA-mediated degradation of microRNAs: a widespread viral strategy? RNA Biol. 12, 579–585 (2015).
Tycowski, K. T. et al. Viral noncoding RNAs: more surprises. Genes Dev. 29, 567–584 (2015).
Murthy, S., Kamine, J. & Desrosiers, R. C. Viral-encoded small RNAs in herpes virus saimiri induced tumors. EMBO J. 5, 1625–1632 (1986).
Lee, S. I., Murthy, S. C., Trimble, J. J., Desrosiers, R. C. & Steitz, J. A. Four novel U RNAs are encoded by a herpesvirus. Cell 54, 599–607 (1988).
Guo, Y. E., Riley, K. J., Iwasaki, A. & Steitz, J. A. Alternative capture of noncoding RNAs or protein-coding genes by herpesviruses to alter host T cell function. Mol. Cell 54, 67–79 (2014).
Jopling, C. L., Schutz, S. & Sarnow, P. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 4, 77–85 (2008).
Machlin, E. S., Sarnow, P. & Sagan, S. M. Masking the 5′ terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA–target RNA complex. Proc. Natl Acad. Sci. USA 108, 3193–3198 (2011).
Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215–233 (2009).
Poliseno, L. & Pandolfi, P. P. PTEN ceRNA networks in human cancer. Methods 77–78, 41–50 (2015).
de Giorgio, A., Krell, J., Harding, V., Stebbing, J. & Castellano, L. Emerging roles of competing endogenous RNAs in cancer: insights from the regulation of PTEN. Mol. Cell. Biol. 33, 3976–3982 (2013).
Lim, L. P. et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433, 769–773 (2005).
Baek, D. et al. The impact of microRNAs on protein output. Nature 455, 64–71 (2008).
Hendrickson, D. G. et al. Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. PLoS Biol. 7, e1000238 (2009).
Vlachos, I. S. et al. DIANA-TarBase v7.0: indexing more than half a million experimentally supported miRNA:mRNA interactions. Nucleic Acids Res. 43, D153–D159 (2015).
Tay, Y., Rinn, J. & Pandolfi, P. P. The multilayered complexity of ceRNA crosstalk and competition. Nature 505, 344–352 (2014).
Shin, C. et al. Expanding the microRNA targeting code: functional sites with centered pairing. Mol. Cell 38, 789–802 (2010).
Chi, S. W., Hannon, G. J. & Darnell, R. B. An alternative mode of microRNA target recognition. Nat. Struct. Mol. Biol. 19, 321–327 (2012).
Alexiou, P., Maragkakis, M., Papadopoulos, G. L., Reczko, M. & Hatzigeorgiou, A. G. Lost in translation: an assessment and perspective for computational microRNA target identification. Bioinformatics 25, 3049–3055 (2009).
Ritchie, W., Flamant, S. & Rasko, J. E. Predicting microRNA targets and functions: traps for the unwary. Nat. Methods 6, 397–398 (2009).
Liu, K., Yan, Z., Li, Y. & Sun, Z. Linc2GO: a human LincRNA function annotation resource based on ceRNA hypothesis. Bioinformatics 29, 2221–2222 (2013).
Ghosal, S., Das, S., Sen, R. & Chakrabarti, J. HumanViCe: host ceRNA network in virus infected cells in human. Front. Genet. 5, 249 (2014).
Joung, J. G., Hwang, K. B., Nam, J. W., Kim, S. J. & Zhang, B. T. Discovery of microRNA–mRNA modules via population-based probabilistic learning. Bioinformatics 23, 1141–1147 (2007).
Tran, D. H., Satou, K. & Ho, T. B. Finding microRNA regulatory modules in human genome using rule induction. BMC Bioinformatics 9, S5 (2008).
Gennarino, V. A. et al. Identification of microRNA-regulated gene networks by expression analysis of target genes. Genome Res. 22, 1163–1172 (2012).
Xia, T. et al. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer. Sci. Rep. 4, 6088 (2014).
Thomson, D. W. et al. Assessing the gene regulatory properties of Argonaute-bound small RNAs of diverse genomic origin. Nucleic Acids Res. 43, 470–481 (2014).
Hafner, M. et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR–CLIP. Cell 141, 129–141 (2010).
Wee, L. M., Flores-Jasso, C. F., Salomon, W. E. & Zamore, P. D. Argonaute divides its RNA guide into domains with distinct functions and RNA-binding properties. Cell 151, 1055–1067 (2012). This study proposes that mammalian miRNAs need to be present in high abundance to function owing to only requiring partial complementarity to targets. This suggests that the ceRNA hypothesis may only explain exceptional circumstances.
Guttman, M. & Rinn, J. L. Modular regulatory principles of large non-coding RNAs. Nature 482, 339–346 (2012).
Hogan, D. J. et al. Anti-miRs competitively inhibit microRNAs in Argonaute complexes. PLoS ONE 9, e100951 (2014).
Gloss, B. S. & Dinger, M. E. The specificity of long noncoding RNA expression. Biochim. Biophys. Acta 1859, 16–22 (2015).
Tan, J. Y. et al. Extensive microRNA-mediated crosstalk between lncRNAs and mRNAs in mouse embryonic stem cells. Genome Res. 25, 655–666 (2015).
Clark, M. B. et al. Genome-wide analysis of long noncoding RNA stability. Genome Res. 22, 885–898 (2012).
Nam, J. W. et al. Global analyses of the effect of different cellular contexts on microRNA targeting. Mol. Cell 53, 1031–1043 (2014).
Bracken, C. P. et al. Global analysis of the mammalian RNA degradome reveals widespread miRNA-dependent and miRNA-independent endonucleolytic cleavage. Nucleic Acids Res. 39, 5658–5668 (2011).
Sugimoto, Y. et al. Analysis of CLIP and iCLIP methods for nucleotide-resolution studies of protein-RNA interactions. Genome Biol. 13, R67 (2012).
Leung, A. K. & Sharp, P. A. Quantifying Argonaute proteins in and out of GW/P-bodies: implications in microRNA activities. Adv. Exp. Med. Biol. 768, 165–182 (2013).
Zhang, B. et al. A dosage-dependent pleiotropic role of Dicer in prostate cancer growth and metastasis. Oncogene 33, 3099–3108 (2014).
Maziere, P. & Enright, A. J. Prediction of microRNA targets. Drug Discov. Today 12, 452–458 (2007).
Rehmsmeier, M. Prediction of microRNA targets. Methods Mol. Biol. 342, 87–99 (2006).
Lagana, A. Computational prediction of microRNA targets. Adv. Exp. Med. Biol. 887, 231–252 (2015).
Wang, X. Computational prediction of microRNA targets. Methods Mol. Biol. 667, 283–295 (2010).
Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P. & Burge, C. B. Prediction of mammalian microRNA targets. Cell 115, 787–798 (2003).
Kertesz, M., Iovino, N., Unnerstall, U., Gaul, U. & Segal, E. The role of site accessibility in microRNA target recognition. Nat. Genet. 39, 1278–1284 (2007).
Betel, D., Koppal, A., Agius, P., Sander, C. & Leslie, C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol. 11, R90 (2010).
Oulas, A. et al. A new microRNA target prediction tool identifies a novel interaction of a putative miRNA with CCND2. RNA Biol. 9, 1196–1207 (2012).
Kiriakidou, M. et al. A combined computational-experimental approach predicts human microRNA targets. Genes Dev. 18, 1165–1178 (2004).
Li, L. et al. 3′UTR shortening identifies high-risk cancers with targeted dysregulation of the ceRNA network. Sci. Rep. 4, 5406 (2014).
Poria, D. K., Guha, A., Nandi, I. & Ray, P. S. RNA-binding protein HuR sequesters microRNA-21 to prevent translation repression of proinflammatory tumor suppressor gene programmed cell death 4. Oncogene http://dx.doi.org/10.1038/onc.2015.235, (2015).
Floor, S. N. & Doudna, J. A. Get in LINE: Competition for newly minted retrotransposon proteins at the ribosome. Mol. Cell 60, 712–714 (2015).
Acknowledgements
The authors thank E. Harvey and K. Patterson for figure preparation, also B. Signal and the Dinger laboratory for useful discussion.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
DATABASES
FURTHER INFORMATION
Glossary
- Long non-coding RNAs
-
(lncRNAs). Transcripts with little or no protein-coding potential that are greater than 200 nucleotides in length.
- Competitive endogenous RNA
-
(ceRNA). RNA that leads to upregulation of expression of a target gene by competing for microRNA binding sites.
- MicroRNA
-
(miRNA). A small (20–22 nucleotide long) non-coding RNA that inhibits gene expression by guiding the RNA-induced silencing complex (RISC) to target genes.
- Pseudogene
-
A duplicated gene, identified through DNA homology to its parent gene but with evolutionarily acquired mutations.
- Circular RNAs
-
(circRNAs). A class of RNAs derived mostly from non-canonical splicing in which the exon ends are joined to form a loop.
- Antisense RNA
-
The reverse complement of a specified RNA. This differs from an antisense transcript, which refers to endogenous antisense transcription of an annotated gene.
- ceRNA networks
-
(competitive endogenous RNA networks). Networks of interactions that arise from the concept that a collective pool of transcripts can synergistically compete for microRNA (miRNA) binding and that a single miRNA can silence several targets.
- miRNA recognition elements
-
(MREs). MicroRNA (miRNA) binding sites that are canonically found in the 3′ untranslated region of a target mRNA and have sequence similarity to the 5′ seed region of the miRNA.
- miRNA sponges
-
Antisense RNA transcripts that inhibit microRNA (miRNA) activity. These molecules can be artificially introduced or, if endogenous, are equivalent to competitive endogenous RNAs.
- 3′ untranslated regions
-
(3′ UTRs). The ends of messenger RNAs that follow the stop codon.
- Dicer
-
A key protein in the microRNA (miRNA) and small interfering RNA (siRNA) biosynthesis pathways. Dicer is an endonuclease that cleaves double-stranded RNA and miRNA precursor transcripts.
- RNA-induced silencing complex
-
(RISC). A protein complex that uses a single stranded guide RNA (for example, a microRNA (miRNA) or small interfering RNA (siRNA)) to elicit post-transcriptional gene silencing.
- Argonaute
-
(AGO). A family of proteins that bind a guide RNA as part of the microRNA (miRNA) or small interfering RNA (siRNA) pathway.
- HITS–CLIP
-
(High-throughput sequencing of RNA isolated by crosslinking immunoprecipitation). A sequencing method to identify microRNA (miRNA) targets and functional miRNAs.
- Small nuclear RNAs
-
(snRNAs). A class of nuclear localized RNAs with roles in splicing and RNA modification.
- SILAC
-
(Stable isotope labelling by amino acids in cell culture). A proteomic approach using quantitative mass spectrometry.
- Polysome profiling
-
The analysis of mRNAs associated with elongating ribosomes to identify translationally active mRNAs.
- Centred pairing
-
A non-canonical mechanism of microRNA (miRNA) targeting in which six or more nucleotides in the centre of the miRNA bind target genes.
- G-bulge
-
MicroRNA (miRNA) targeting of complementary nucleotides where a guanosine (G) nucleotide is skipped resulting in a 'bulge'.
- Encyclopedia of DNA Elements
-
(ENCODE). An international consortium with the goal to build a comprehensive list of functional elements in the human genome.
- Sensor-seq
-
A high-throughput assay of microRNA (miRNA) activity as measured by high-throughput sequencing of a pool of reporter constructs each with binding sites for individual miRNAs.
- Individual-nucleotide resolution CLIP
-
(iCLIP). A crosslinking immunoprecipitation (CLIP) technique for identifying protein–RNA interactions, in which the direct crosslinking site can be identified where the reverse transcribed cDNA is truncated.
- Pathway divergence
-
A signalling pathway that is amplified when signals from the same ligand activate a variety of different effectors leading to diverse cellular responses.
- Small interfering RNA
-
(siRNA). siRNAs, which are also called silencing RNAs, act within the RNA-induced silencing complex (RISC) to guide gene silencing. The term can refer to a synthetic RNA duplex or an endogenously derived RNA from a double-stranded precursor.
- CRISPR
-
A specific gene-editing technique using guide RNAs and CRISPR-associated protein 9 (Cas9).
Rights and permissions
About this article
Cite this article
Thomson, D., Dinger, M. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet 17, 272–283 (2016). https://doi.org/10.1038/nrg.2016.20
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrg.2016.20
This article is cited by
-
Long non-coding RNA ACTA2-AS1 suppresses metastasis of papillary thyroid cancer via regulation of miR-4428/KLF9 axis
Clinical Epigenetics (2024)
-
LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism
BMC Cancer (2024)
-
Ferroptosis: a promising candidate for exosome-mediated regulation in different diseases
Cell Communication and Signaling (2024)
-
Long noncoding RNA XIST promotes cell proliferation and migration in diabetic foot ulcers through the miR-126-3p/EGFR axis
Diabetology & Metabolic Syndrome (2024)
-
Identification of BACH1-IT2-miR-4786-Siglec-15 immune suppressive axis in bladder cancer
BMC Cancer (2024)